Why are Some People More Likely to Develop Devastating Lung Disease than Others?

Three genes are associated with a higher risk of a serious lung disease known as idiopathic pulmonary fibrosis (IPF).

New study has discovered parts of the DNA that put some people at higher risk of a serious lung disease known as idiopathic pulmonary fibrosis (IPF). The findings of the study are published in the American Journal of Respiratory and Critical Care Medicine.//

About 6,000 people are diagnosed every year in the UK, though this number appears to be rising. There are no cures for IPF, and current treatments can only slow the progression of the disease. This means an improved understanding of what causes IPF is vital in the development of more effective treatments.

Pulmonary Fibrosis - Causes, Symptoms, Diagnosis, Treatment, Prognosis
Do you find yourself out of breath and coughing a lot lately? Do you work in dust prone places? Well, then you might have pulmonary fibrosis.

‘Idiopathic pulmonary fibrosis is a devastating lung disease where scar tissue builds up in the lungs. This scarring makes it hard to breathe, and half of all patients die within three years of diagnosis. ’

Professor Louise Wain and Dr. Richard Allen from the University of Leicester, and Professor Gisli Jenkins from the University of Nottingham, led the study that included collaborators from over 30 institutions across six countries. The leadership of this collaboration unites the NIHR Biomedical Research Centres (BRCs) of Leicester and Nottingham - partnerships between their respective universities, Nottingham University Hospitals NHS Trust and the University Hospitals of Leicester NHS Trust. The purpose of the NIHR BRCs is to take scientific discoveries and translate them into treatments and care pathways for the direct benefit of patients.

The research teams compared the DNA of 4,000 people with IPF to 20,000 people without IPF. In total, they investigated over 10 million changes in the DNA and found that people with IPF were more likely to have changes in three genes that have not previously been known to be involved with the disease. These genes suggest biological pathways which crucially could be potential targets for new drugs.

One of these genes lies in a pathway that has recently been shown to promote fibrosis in the lungs. There are currently drugs under development that can target this pathway and might benefit patients. The other two genes highlight pathways not previously investigated for IPF but which might drive the development of new treatments in the future.

Three-drug Regimen and Idiopathic Pulmonary Fibrosis
The three-drug regimen may not be a good choice in patients with idiopathic pulmonary fibrosis.

Dr. Richard Allen, Action for Pulmonary Fibrosis Research Fellow at the University of Leicester, said: "These are really exciting discoveries and improve our understanding of the disease. Hopefully, this research will help in the development of treatments that are desperately needed for this devastating disease."

Professor Louise Wain, British Lung Foundation Chair in Respiratory Research at the University of Leicester, said: "Genetic studies hold real promise in helping us find new treatments for IPF. This study was undertaken by a large international team of scientists and doctors and wouldn't have been possible were it not for patients with IPF contributing their genetic data for research. The next step is to find out how these findings can enable us to find new and better treatments for IPF."

Short or Long Sleep Linked to Pulmonary Fibrosis
People who report they regularly sleep 4 hours or less in a day doubled their chance of having pulmonary fibrosis while those sleeping 11 hours or longer in a day tripled their chance of having the disease, reports a new study.

Ian Jarrold, Head of Research at the British Lung Foundation, said: "IPF kills more people than leukemia every year in the UK, but it has been a major challenge to identify the biological factors that are responsible for this insidious lung condition.

"Genomics has helped us to take big steps forward in finding new treatments for this condition. By teasing out the complex relationships between different genes, we have a huge opportunity to turn the tide against IPF.

New Cause For Pulmonary Fibrosis Found
Genetic mutation that causes a severe lung disease called idiopathic pulmonary fibrosis (IPF) has been identified.

"We urgently need treatments that can stop lung scarring in its tracks. The exciting prospect of three newly identified genes, which could lead us to these new treatments, brings hope to the many thousands of people whose lives have been devastated by IPF."

Steve Jones, Chair of Action for Pulmonary Fibrosis, said: "Idiopathic Pulmonary Fibrosis (IPF) is a devastating disease, which accounts for one percent of all deaths in the UK. To find a cure, it is vital that we understand the genetic changes associated with the process of lung fibrosis. This path-breaking research has identified three genes, which could lead to new treatments bringing hope to a large number of people around the world living with the disease."

Source-Eurekalert